Each year, more than 700,000 people lose their lives to drug-resistant infections, and this number could climb to 10 million by the year 2050 if nothing is done help combat it. Now, the COVID-19 pandemic is exacerbating the problem.
Helping Pharmacists Fight Antimicrobial Resistance – Q&A with Dr. Catherine Duggan, CEO, International Pharmaceutical Federation (FIP)
October is American Pharmacists Month, and we’ve teamed up with the International Pharmaceutical Federation (FIP) to bring you an interview with Dr. Catherine Duggan, CEO, about how pharmacists and the pharmaceutical industry at large can contribute to the fight against antimicrobial resistance.
What Happened to My Baseline? Evidence-Based Care in the COVID-19 Era
“Baselines are used throughout healthcare to evaluate safety, performance, and fiscal execution at the macro and micro level,” writes John Hurst, Pharm D, BCIDP and Senior Director of Antimicrobial Stewardship at bioMérieux.
Acute Kidney Injury is a Frequent Complication of COVID-19
Clinical presentation of kidney involvement from COVID-19 can range from mild proteinuria to progressive AKI, requiring renal replacement therapy (RRT).
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...